HomeCirculationVol. 60, No. 3Possible hazards of oral contraceptive use. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyRedditDiggEmail Jump toFree AccessAbstractPDF/EPUBPossible hazards of oral contraceptive use. W B Kannel W B KannelW B Kannel Search for more papers by this author Originally published1 Sep 1979https://doi.org/10.1161/01.CIR.60.3.490Circulation. 1979;60:490–491"Possible hazards of oral contraceptive use.." Circulation, 60(3), pp. 490–491 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Alhaj W, Moharram B, Al-Maqtari T, Al-Mahbashi H, Al-Doaiss A and Iqbal A (2022) The Potential of Jatropha variegata Fruits as a Natural Contraceptive: Antifertility Activity and Phytochemical Analysis, Evidence-Based Complementary and Alternative Medicine, 10.1155/2022/1365526, 2022, (1-11), Online publication date: 21-Feb-2022. Tekwu E, Beng V and Kuete V (2013) African Medicinal Plants Acting on the Reproductive, Cardiovascular, and Central Nervous Systems Medicinal Plant Research in Africa, 10.1016/B978-0-12-405927-6.00022-9, (805-841), . Unny R, Chauhan A, Joshi Y, Dobhal M and Gupta R (2003) A review on potentiality of medicinal plants as the source of new contraceptive principles, Phytomedicine, 10.1078/094471103321659997, 10:2-3, (233-260), Online publication date: 1-Jan-2003. Schnellbacher K (1996) Kardiale Beteiligung bei endokrinen, metabolischen und hämatologischen Erkrankungen sowie bei Ernährungsstörungen Herzkrankheiten, 10.1007/978-3-642-97605-6_72, (1668-1685), . Schnellbacher K (1989) Das Herz bei endokrinen Erkrankungen, Ernährungsstörungen, Stoffwechsel- und Bluterkrankungen Herzkrankheiten, 10.1007/978-3-642-97060-3_64, (1407-1421), . Sokolow M and Mcllroy M (1985) Koronare Herzkrankheit Kardiologie, 10.1007/978-3-642-69607-7_8, (138-246), . Peiffer J (1984) Neuropathologie Pathologie, 10.1007/978-3-642-50221-7_1, (1-287), . Schnellbacher K (1982) Das Herz bei endokrinen Erkrankungen, Ernährungsstörungen, Stoffwechsel- und Bluterkrankungen Herzkrankheiten, 10.1007/978-3-642-96617-0_58, (1442-1455), . Ciavatti M, Davenas E, Michel G and Renaud S (1982) Oral contraceptive and platelet lipid biosynthesis in female rats: Dose-response relationship, Lipids, 10.1007/BF02535185, 17:2, (111-114), Online publication date: 1-Feb-1982. BEAUMONT J and BEAUMONT V (2013) Immune Reactivity and the Vascular Risk in Oral Contraceptive Users*, American Journal of Reproductive Immunology, 10.1111/j.1600-0897.1981.tb00143.x, 1:3, (119-125), Online publication date: 1-Jul-1981. Dalen J and Hickler R (1981) Oral contraceptives and cardiovascular disease, American Heart Journal, 10.1016/0002-8703(81)90231-3, 101:5, (626-639), Online publication date: 1-May-1981. Foegh M, Damgaard-Pedersen F, Gormsen J, Knudsen J and Schou G (1980) Oral levo-norgestrel — Testosterone effects on spermatogenesis, hormone levels, coagulation factors and lipoproteins in normal men, Contraception, 10.1016/S0010-7824(80)80016-3, 21:4, (381-391), Online publication date: 1-Apr-1980. Foegh M, Nicol K, Petersen I and Schou G (1980) Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men, Contraception, 10.1016/0010-7824(80)90035-9, 21:6, (631-640), Online publication date: 1-Jun-1980. September 1, 1979Vol 60, Issue 3Article InformationMetrics Copyright © 1979 by American Heart Associationhttps://doi.org/10.1161/01.CIR.60.3.490 Originally publishedSeptember 1, 1979 PDF download Advertisement